Creighton University School of Medicine, Omaha, NE 68131, USA.
Am Fam Physician. 2011 Mar 15;83(6):719-24.
Red blood cell transfusions are used to treat hemorrhage and to improve oxygen delivery to tissues. Transfusion of red blood cells should be based on the patient's clinical condition. Indications for transfusion include symptomatic anemia (causing shortness of breath, dizziness, congestive heart failure, and decreased exercise tolerance), acute sickle cell crisis, and acute blood loss of more than 30 percent of blood volume. Fresh frozen plasma infusion can be used for reversal of anticoagulant effects. Platelet transfusion is indicated to prevent hemorrhage in patients with thrombocytopenia or platelet function defects. Cryoprecipitate is used in cases of hypofibrinogenemia, which most often occurs in the setting of massive hemorrhage or consumptive coagulopathy. Transfusion-related infections are less common than noninfectious complications. All noninfectious complications of transfusion are classified as noninfectious serious hazards of transfusion. Acute complications occur within minutes to 24 hours of the transfusion, whereas delayed complications may develop days, months, or even years later.
红细胞输注用于治疗出血和改善组织的氧输送。输血应基于患者的临床情况。输血的适应证包括有症状的贫血(引起呼吸急促、头晕、充血性心力衰竭和运动耐量降低)、急性镰状细胞危象和超过 30%血容量的急性失血。新鲜冷冻血浆输注可用于逆转抗凝作用。血小板输注用于预防血小板减少或血小板功能缺陷患者的出血。冷沉淀用于纤维蛋白原减少症,这种情况最常发生在大量出血或消耗性凝血病的情况下。输血相关感染比非传染性并发症少见。输血的所有非传染性并发症均归类为输血的非传染性严重危害。急性并发症发生在输血后几分钟到 24 小时内,而迟发性并发症可能在数天、数月甚至数年后出现。